Fig. 3From: The appropriate dosing of erenumab for migraine prevention after multiple preventive treatment failures: a critical appraisalPatients with chronic migraine and medication overuse: effect of erenumab on monthly migraine days, monthly migraine-specific medication days, and 50% reduction in monthly migraine days from baseline according to prior preventive treatment failures in the NCT02066415 trial [12, 13]Back to article page